Lorazepam Mega Study
Contents
Lorazepam
Lorazepam

Related

A
Count
A
Treatments
A
Effects
A
User Variables 6
A
Measurements 12

Tags

Lorazepam

Treatment Effectiveness

User reported effectiveness ratings Lorazepam for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Panic Disorder 57% 29% 0% 7% 7% 14
Restless Legs Syndrome 13% 31% 0% 50% 6% 16

Below is the degree of change seen after Lorazepam is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Lorazepam Info

Property Value
Variable Name Lorazepam
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 13.601244633503
Mean 0.33285025 count
Median 0.25 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 3
Number of Measurements 12
Number of Measurements (including those generated by tagged, joined, or child variables) 12
Public true
Onset Delay 30 minutes
Standard Deviation 0.22447848799587
Unit Count
User Variables 6
UPC 811426923497
Variable Category Treatments
Variable ID 94228
Variance 0.075906396470913